Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-6-8
pubmed:abstractText
To report our experience with bacille Calmette-Guérin (BCG) perfusion therapy for transitional cell carcinoma in situ of the upper urinary tract. BCG perfusion therapy is widely used to treat transitional cell carcinoma in situ of the upper urinary tract. However, it has not yet been established as a standard treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1527-9995
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1084-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15183955-Administration, Intravesical, pubmed-meshheading:15183955-Adult, pubmed-meshheading:15183955-Aged, pubmed-meshheading:15183955-Aged, 80 and over, pubmed-meshheading:15183955-BCG Vaccine, pubmed-meshheading:15183955-Carcinoma, Transitional Cell, pubmed-meshheading:15183955-Carcinoma in Situ, pubmed-meshheading:15183955-Drug Administration Schedule, pubmed-meshheading:15183955-Female, pubmed-meshheading:15183955-Follow-Up Studies, pubmed-meshheading:15183955-Humans, pubmed-meshheading:15183955-Hydronephrosis, pubmed-meshheading:15183955-Lymphatic Metastasis, pubmed-meshheading:15183955-Male, pubmed-meshheading:15183955-Middle Aged, pubmed-meshheading:15183955-Neoplasm Recurrence, Local, pubmed-meshheading:15183955-Survival Rate, pubmed-meshheading:15183955-Treatment Outcome, pubmed-meshheading:15183955-Urinary Bladder Neoplasms, pubmed-meshheading:15183955-Urologic Neoplasms
pubmed:year
2004
pubmed:articleTitle
Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
pubmed:affiliation
Department of Urology, Nagasaki University School of Medicine, Nagasaki, Japan.
pubmed:publicationType
Journal Article, Clinical Trial